Dr Anna Mislang 520 South Road, Kurralta Park, South Australia 5037

Welcome to Dr Anna Mislang's medical oncology practice, located in Kurralta Park, South Road, Australia. Dr Mislang is a highly experienced and dedicated medical oncologist, currently practicing at the Icon Cancer Centre Adelaide. She obtained her Bachelor of Medicine, Bachelor of Surgery (MBBS) from St Luke's College of Medicine in the Philippines and completed postgraduate training at the prestigious Royal Adelaide Hospital.

Dr Mislang further honed her skills and expertise through advanced medical oncology training at the Royal Adelaide Hospital, Flinders Medical Centre, and Royal Darwin Hospital. In 2017, she underwent formal training in geriatric oncology at the Nuovo Ospedale-Santo Stefano, Instituto Toscano Tumori in Prato, Italy. Her commitment to advancing cancer research led her to serve as a clinical fellow under the guidance of Professor Michael Brown at the RAH Cancer Clinical Trials Unit, where she oversaw several Phase III immuno-oncology clinical trials and collaborated on innovative research proposals.

With a particular interest in the care of older patients with cancer and the prediction and management of treatment-related toxicities, Dr Mislang offers comprehensive and compassionate care to patients with a broad range of solid tumor malignancies. Her areas of special clinical interest include breast cancer, gastrointestinal cancer, genitourinary cancer, geriatric cancer, and melanoma.

At Dr Anna Mislang's practice, patients can expect personalized and evidence-based treatment plans tailored to their unique needs. Dr Mislang stays at the forefront of medical advancements and utilizes the latest technologies to provide the highest standard of care. She is dedicated to empowering her patients with knowledge, support, and guidance throughout their cancer journey.

If you or a loved one are seeking expert medical oncology care in Australia, Dr Anna Mislang's practice is a point of interest that you can trust. Contact us today to schedule a consultation and take a step towards a brighter and healthier future.

In addition to her clinical practice, Dr Mislang is actively involved in research and has contributed to numerous studies, including "A Study of AK112, a PD-1/VEGF Bispecific Antibody, for Advanced Solid Tumors" and "A Study to Evaluate the Safety, Pharmacokinetics, and Antitumor Activity of AK127 in Combination With AK104 in Advanced and Metastatic Solid Tumors."